2021 annual financial data
ProQR Therapeutics 2021 Operating margin
Direct answer
Operating margin was -4,285.39%.
Operating income was -57.21M EUR and net income was -60.74M EUR.
Operating cash flow was -26.01M EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1.34M EUR
- Operating income
- -57.21M EUR
- Net income
- -60.74M EUR
- Operating cash flow
- -26.01M EUR